Title

Exposure To Monomethylarsonous Acid (MmaIii) Leads To Altered Selenoprotein Synthesis In A Primary Human Lung Cell Model

Keywords

Antioxidant response element; Arsenic; Carcinogenesis; Monomethylarsonous acid; Selenium; Thioredoxin reductase

Abstract

Monomethylarsonous acid (MMAIII), a trivalent metabolite of arsenic, is highly cytotoxic and recent cell culture studies suggest that it might act as a carcinogen. The general consensus of studies indicates that the cytotoxicity of MMAIII is a result of increased levels of reactive oxygen species (ROS). A longstanding relationship between arsenic and selenium metabolism has led to the use of selenium as a supplement in arsenic exposed populations, however the impact of organic arsenicals (methylated metabolites) on selenium metabolism is still poorly understood. In this study we determined the impact of exposure to MMAIII on the regulation of expression of TrxR1 and its activity using a primary lung fibroblast line, WI-38. The promoter region of the gene encoding the selenoprotein thioredoxin reductase 1 (TrxR1) contains an antioxidant responsive element (ARE) that has been shown to be activated in the presence of electrophilic compounds. Results from radiolabeled selenoproteins indicate that exposure to low concentrations of MMAIII resulted in increased synthesis of TrxR1 in WI-38 cells, and lower incorporation of selenium into other selenoproteins. MMAIII treatment led to increased mRNA encoding TrxR1 in WI-38 cells, while lower levels of mRNA coding for cellular glutathione peroxidase (cGpx) were detected in exposed cells. Luciferase activity of TrxR1 promoter fusions increased with addition of MMAIII, as did expression of a rat quinone reductase (QR) promoter fusion construct. However, MMAIII induction of the TRX1 promoter fusion was abrogated when the ARE was mutated, suggesting that this regulation is mediated via the ARE. These results indicate that MMAIII alters the expression of selenoproteins based on a selective induction of TrxR1, and this response to exposure to organic arsenicals that requires the ARE element. © 2008 Elsevier Inc. All rights reserved.

Publication Date

9-1-2009

Publication Title

Toxicology and Applied Pharmacology

Volume

239

Issue

2

Number of Pages

130-136

Document Type

Article

Personal Identifier

scopus

DOI Link

https://doi.org/10.1016/j.taap.2008.11.011

Socpus ID

68949194237 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/68949194237

This document is currently not available here.

Share

COinS